Adult Varicella Vaccination: Two-Dose Requirement
Adults without evidence of varicella immunity require two doses of single-antigen varicella vaccine administered subcutaneously, 4-8 weeks apart. 111
Dosing Schedule for Adults (≥13 Years)
The ACIP guidelines are unequivocal on this point:
- First dose: 0.5 mL subcutaneously
- Second dose: 0.5 mL subcutaneously, administered 4-8 weeks after the first dose
- Flexibility: If more than 8 weeks elapse after the first dose, the second dose may still be administered without restarting the schedule 11
The FDA drug label for VARIVAX confirms that for adolescents and adults, two doses may be separated by a minimum of 1 month (4 weeks) 2, though the ACIP recommendation of 4-8 weeks is the standard clinical practice guideline.
Key Clinical Points
Why Two Doses?
Adults require two doses because single-dose vaccination provides only moderate protection (82-85%) against varicella of any severity 3. The two-dose regimen improves vaccine effectiveness by at least 10% and provides more durable immunity without evidence of waning 3.
High-Priority Adult Groups
While all healthy adults without evidence of immunity should receive two doses, certain groups warrant special consideration and priority 11:
- Healthcare personnel
- Household contacts of immunocompromised persons
- Teachers and daycare employees
- College students and military personnel
- Nonpregnant women of childbearing age
- International travelers
Important Contraindications
Pregnancy is an absolute contraindication 2. Women should:
- Avoid pregnancy for at least 1 month after each vaccine dose
- Receive the first dose before hospital discharge if found to be non-immune postpartum
- Receive the second dose 4-8 weeks later 1
Common Pitfalls to Avoid
Do not use MMRV vaccine in adults - Only single-antigen varicella vaccine is licensed for persons aged >13 years 11
Do not assume birth before 1980 equals immunity - This is NOT considered evidence of immunity for pregnant women or healthcare personnel 4
Avoid salicylates for 6 weeks post-vaccination - Risk of Reye syndrome 2
Respect immune globulin interactions - Blood products may interfere with vaccine response 2
The evidence base from ACIP guidelines 11111 and FDA labeling 22 is consistent and definitive: two doses, 4-8 weeks apart, no exceptions for immunocompetent adults.